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Authors' Reply
We thank Dr. Kadri Altundag for the important comments on our study. We also wanted to investigate the role of natriuretic peptide and cardiac troponins in the prediction of chemotherapy-induced left ventricular dysfunction (LVD). This issue could not be evaluated because the present study was retrospective and cardiac biomarkers were not measured in many of the study subjects. We agree that the measurement of several cardiac biomarkers would be useful in the early identification of chemotherapy-induced LVD [1, 2] . However, in the early-stage prediction of chemotherapy-induced LVD, the optimal timing for the measurement of biomarker remains unclear. Therefore, further large-scale randomized studies will be needed to investigate this issue.
